A majority of lenders did not favour accepting a non-compliant EMD since that would require changing the terms of the RFP and reinviting bids. Some lenders, however, were worried that the alternative option – liquidation of the twin Srei companies – will result in lower recoveries.
Moderna shares soar 135% in a day after cancer vaccine succeeds in late-stage trial
Moderna shares surged after its personalized mRNA cancer vaccine trial showed positive results. The treatment, combined with Keytruda, reduced melanoma recurrence and spread significantly. This